We provide you with 20 years of free, institutional-grade data for LUNG stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of LUNG. Explore the full financial landscape of LUNG stock.
| Reported Date | CIK | Ticker | Type | |
|---|---|---|---|---|
| 2023-11-03 | 0001127537 | LUNG | 10-Q | Url |
| 2023-08-04 | 0001127537 | LUNG | 10-Q | Url |
| 2023-05-08 | 0001127537 | LUNG | 10-Q | Url |
| 2023-03-01 | 0001127537 | LUNG | 10-K | Url |
| 2022-11-08 | 0001127537 | LUNG | 10-Q | Url |
| 2022-08-08 | 0001127537 | LUNG | 10-Q | Url |
| 2022-05-09 | 0001127537 | LUNG | 10-Q | Url |
| 2022-03-01 | 0001127537 | LUNG | 10-K | Url |
| 2021-11-09 | 0001127537 | LUNG | 10-Q | Url |
| 2021-08-10 | 0001127537 | LUNG | 10-Q | Url |
| 2021-05-12 | 0001127537 | LUNG | 10-Q | Url |
| 2021-03-15 | 0001127537 | LUNG | 10-K | Url |
| 2020-11-13 | 0001127537 | LUNG | 10-Q | Url |
| 2020-09-04 | 0001127537 | LUNG | S-1 | Url |
| 2020-02-28 | 0001127537 | LUNG | S-1 | Url |
Pulmonx Corporation(NASDAQ:LUNG) 
Pulmonx Corporation, a medical technology company, designs, develops, manufactures, and markets minimally invasive medical devices for the diagnosis and treatment of chronic obstructive pulmonary diseases. It offers Zephyr Endobronchial Valve, a solution for the treatment of bronchoscopic in adult p...
Website: http://www.pulmonx.com
Founded: 1995
Full Time Employees: 180
CEO: Glendon E. French
Sector: Other
Industry: Other
The information provided in this report about LUNG stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.